Stocktoria

Ingevity Corp NGVT

NYSE · stock · Chemicals & Allied Products · website · IPO 2016-05-02 · LEI

Ingevity Corp financials (annual)

Revenue
$908.3M $972.4M $1.13B $1.29B $1.22B $1.39B $1.67B $1.22B $1.20B $1.17B 2016201720182019202020212022202320242025
Net income
$35.2M $126.5M $169.1M $183.7M $181.4M $118.1M $211.6M -$5.4M -$430.3M -$167.1M 2016201720182019202020212022202320242025
Free cash flow
$158.1M $160.9M $270.3M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.2B$1.2B$1.2B$1.7B$1.4B$1.2B$1.3B$1.1B$972.4M$908.3M
Gross profit$461.5M$464.8M$445.0M$570.1M$512.8M$465.5M$482.0M$416.8M$329.0M$274.4M
R&D expense$28.4M$24.5M$25.4M$30.3M$26.3M$22.6M$19.7M$21.5M$19.8M$17.6M
SG&A expense$171.2M$157.8M$161.8M$198.8M$179.3M$149.4M$163.1M$132.4M$106.4M$96.4M
Operating income$418.7M$425.9M$423.2M$452.6M$422.2M$397.9M$396.9M$320.5M$242.7M$163.6M
Interest expense$78.3M$97.8M$93.3M$61.8M$51.7M$47.1M$54.6M$33.2M$18.1M$19.3M
Income tax$8.2M-$19.1M$24.2M$58.0M$44.7M$53.7M$44.2M$40.0M$29.6M$42.6M
Net income-$167.1M-$430.3M-$5.4M$211.6M$118.1M$181.4M$183.7M$169.1M$126.5M$35.2M
EPS (diluted)$-4.61$-11.85$-0.15$5.50$2.95$4.37$4.35$3.97$2.97$0.83
Operating cash flow$331.2M$128.6M$205.1M$313.4M$293.3M$352.4M$275.7M$252.0M$174.3M$127.9M
Free cash flow$270.3M$160.9M$158.1M
Cash & equivalents$78.1M$68.0M$95.9M$76.7M$275.4M$257.7M$56.5M$77.5M$87.9M$30.5M
Inventory$186.0M$195.9M$308.8M$335.0M$241.2M$189.0M$212.5M$191.4M$160.0M$151.2M
Total assets$1.7B$2.0B$2.6B$2.7B$2.5B$2.3B$2.1B$1.3B$929.6M$832.8M
Total liabilities$1.6B$1.8B$2.0B$2.0B$1.8B$1.7B$1.6B$976.5M$651.7M$698.2M
Shareholders' equity$29.7M$195.2M$631.4M$698.3M$673.8M$642.1M$530.8M$338.7M$277.9M$134.6M

Growth · year-over-year · Revenue CAGR 2.8%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-2.7%-1.3%-27.1%+19.9%+14.4%-5.9%+14.1%+16.6%+7.1%
Net income growth-102.6%+79.2%-34.9%-1.3%+8.6%+33.7%+259.4%-55.8%
EPS growth-102.7%+86.4%-32.5%+0.5%+9.6%+33.7%+257.8%-56.1%
Free cash flow growth+68.0%+1.8%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.